Weight Loss News and Research

Latest Weight Loss News and Research

Low-fat diet improves mood and memory skills, says new study

After one year, a low-calorie, low-fat diet appears more beneficial to dieters' mood than a low-carbohydrate plan with the same number of calories, according to a report in the November 9 issue of Archives of Internal Medicine, one of the JAMA/Archives journals.

10 Nov 2009

Yo-yo dieting and sugar-bingeing can lead to anxiety and withdrawal symptoms

In research that sheds light on the perils of yo-yo dieting and repeated bouts of sugar-bingeing, researchers from The Scripps Research Institute have shown in animal models that cycling between periods of eating sweet and regular-tasting food can activate the brain's stress system and generate overeating, anxiety, and withdrawal-like symptoms.

10 Nov 2009

Public health experts urge Congress not to overlook the needs of Americans with "morbid obesity"

As the House of Representatives and the Senate debate companion bills to make health care more affordable and accessible, a coalition of obesity and public health experts today urged Congress not to overlook the needs of the more than 15 million Americans who suffer from severe obesity and are at the greatest risk for chronic disease and death.

9 Nov 2009

Renewal Laboratories to produce functional beverages with anti-oxidants and omega3 fatty acids

Renewal Laboratories announced today that it has developed a patent pending process to produce functional beverages with important anti-oxidants and omega3 fatty acids. Natural, nutritionally important supplements such as Coenzyme Q10, resveratrol, and omega3 fish oil may now be offered in appealing and refreshing drinks.

9 Nov 2009

$1.85 million grant to study how digital games can improve players' health behaviors and outcomes

The Robert Wood Johnson Foundation (RWJF) today announced more than $1.85 million in grants for research that will offer unprecedented insight into how digital games can improve players' health behaviors and outcomes. With funding from RWJF's Health Games Research national program, nine research teams across the country will conduct extensive studies to discover, for example, how the popular dance pad video game Dance Dance Revolution might help Parkinson's patients reduce the risk of falling, how Wii Active might be most effectively implemented in high schools to help overweight students lose weight, how a mobile phone game with a breath interface might help smokers quit or reduce their tobacco use, or how facial recognition games might be designed to help people with autism learn to identify others' emotions.

From Evident Corporation - Life Sciences 6 Nov 2009

Health-At-Every-Size approach has long-term beneficial effects, shows study

Most weight-control strategies emphasize energy-restricted diets and increased physical activity - and most are not effective over the long term. In a study of a "weight-acceptance" intervention, published in the November 2009 issue of the Journal of the American Dietetic Association, researchers found that there could be long-term beneficial effects on certain eating behaviors using a weight- acceptance intervention approach.

5 Nov 2009

Significant behavioral changes needed to maintain weight loss

Americans continue to get heavier. Most weight control methods short of bariatric surgery are generally considered ineffective in preventing obesity or reducing weight. The term energy gap was coined to estimate the change in energy balance (intake and expenditure) behaviors required to achieve and sustain reduced body weight outcomes in individuals and populations.

5 Nov 2009

"Alternate-day fasting" reduces body weight and improves cardio health: Study

Restricting daily calorie intake is a common plan to help obese and overweight people slim down to healthier weights. But the regime requires a daily 15 to 40 percent calorie reduction, which makes sticking to the diet hard for many.

4 Nov 2009

Avoiding foods high in AGE toxins can reduce inflammation and restore the body's natural defenses

Researchers from Mount Sinai School of Medicine report that cutting back on the consumption of processed and fried foods, which are high in toxins called Advanced Glycation End products (AGEs), can reduce inflammation and actually help restore the body's natural defenses regardless of age or health status. These benefits are present even without changing caloric or nutrient intake.

4 Nov 2009

Cutting back on the consumption of AGEs can reduce inflammation, report researchers

4 Nov 2009

Scientists identify compounds that hold promise for treating parasitic infection

Using an unconventional approach that they designed, University of Pittsburgh drug discoverers and their collaborators at Walter Reed Army Institute of Research have identified compounds that hold promise for treating leishmaniasis, a parasitic infection that many consider one of the world's most overlooked diseases.

4 Nov 2009

Lap band surgery effective for morbidly obese adolescents, improves glucose metabolism

Washington, DC-A surgeon now at Children's National Medical Center and his colleagues from New York University have found laparoscopic adjustable gastric banding (Lap band) to improve the health of morbidly obese adolescents.

4 Nov 2009

Special commentary on obesity management

The November issue of the Journal of the American Dietetic Association features a commentary by James O. Hill, an honorary ADA member, professor of pediatrics and medicine and director of the Center for Human Nutrition at the University of Colorado-Denver. He is also co-founder of America on the Move, a national weight gain prevention initiative that aims to inspire Americans to make small changes in how much they eat and how much they move to prevent weight gain.

3 Nov 2009

Lifestyle changes prevents type 2 diabetes in people at high risk for developing the disease: Study

Sustaining modest weight loss for 10 years, or taking an anti-diabetic drug over that time, can prevent or lower the incidence of type 2 diabetes in people at high risk for developing the disease, according to the Diabetes Prevention Program Outcomes Study (DPPOS), a long-term follow-up to a landmark 2001 diabetes prevention study.

3 Nov 2009

FDA update on BYETTA injection: Amylin Pharmaceuticals and Eli Lilly respond

Amylin Pharmaceuticals, Inc., and Eli Lilly and Company today issued the following statement in response to the U.S. Food and Drug Administration (FDA) update on BYETTA® (exenatide) injection.

3 Nov 2009

Interim data from Schering-Plough's narlaprevir Phase IIa study

Schering-Plough Corporation reported that interim results from an ongoing Phase IIa study of narlaprevir (SCH 900518), its investigational, once-daily protease inhibitor, demonstrated potent antiviral activity in treatment-naive patients with chronic hepatitis C virus (HCV) genotype 1.

3 Nov 2009

Obese Britons suffer the real cost of obesity in every area of their lives, says new study

Half of Britain's obese are seriously damaging their wealth prospects as well as their health, a new study has revealed.

1 Nov 2009

Shire to present key data on ADHD treatments at national psychiatric meeting

Shire plc, the global specialty biopharmaceutical company, announced today that it will present key scientific data on its Attention-Deficit/Hyperactivity Disorder (ADHD) treatments, INTUNIV- (guanfacine) Extended Release Tablets, Vyvanse- (lisdexamfetamine dimesylate) Capsules CII, and Daytrana- (methylphenidate transdermal system) CII, at a national meeting of psychiatrists to be held October 27 - November 1 in Honolulu.

31 Oct 2009

Schering-Plough receives FDA complete response letter regarding PEGINTRON

Schering-Plough Corp. announced the U.S. Food and Drug Administration (FDA) has issued a complete response letter to the company's supplemental Biologics License Application regarding PEGINTRON® (pegylated interferon alfa-2b) for the adjuvant treatment of patients with stage III malignant melanoma after complete lymphadenectomy.

31 Oct 2009

FDA approves an expanded indication for BYETTA injection

Amylin Pharmaceuticals, Inc., and Eli Lilly and Company (NYSE: LLY) today announced that the U.S. Food and Drug Administration (FDA) has approved an expanded indication for BYETTA® (exenatide) injection. BYETTA is now approved for use as a stand-alone medication (monotherapy) along with diet and exercise to improve glycemic control in adults with type 2 diabetes.

31 Oct 2009

Weight Loss News and Research

Latest Weight Loss News and Research

Low-fat diet improves mood and memory skills, says new study

Yo-yo dieting and sugar-bingeing can lead to anxiety and withdrawal symptoms

Public health experts urge Congress not to overlook the needs of Americans with "morbid obesity"

Renewal Laboratories to produce functional beverages with anti-oxidants and omega3 fatty acids

$1.85 million grant to study how digital games can improve players' health behaviors and outcomes

Health-At-Every-Size approach has long-term beneficial effects, shows study

Significant behavioral changes needed to maintain weight loss

"Alternate-day fasting" reduces body weight and improves cardio health: Study

Avoiding foods high in AGE toxins can reduce inflammation and restore the body's natural defenses

Cutting back on the consumption of AGEs can reduce inflammation, report researchers

Scientists identify compounds that hold promise for treating parasitic infection

Lap band surgery effective for morbidly obese adolescents, improves glucose metabolism

Special commentary on obesity management

Lifestyle changes prevents type 2 diabetes in people at high risk for developing the disease: Study

FDA update on BYETTA injection: Amylin Pharmaceuticals and Eli Lilly respond

Interim data from Schering-Plough's narlaprevir Phase IIa study

Obese Britons suffer the real cost of obesity in every area of their lives, says new study

Shire to present key data on ADHD treatments at national psychiatric meeting

Schering-Plough receives FDA complete response letter regarding PEGINTRON

FDA approves an expanded indication for BYETTA injection

How microRNA is transforming science: From discovery to diagnostics

Advancing benzodiazepine detection

The Surgeon-Scientist Pioneering Regenerative Engineering

Weight Loss News and Research

Latest Weight Loss News and Research

How microRNA is transforming science: From discovery to diagnostics

Advancing benzodiazepine detection

The Surgeon-Scientist Pioneering Regenerative Engineering

Newsletters you may be interested in